Clincosm LogoSign in Get a demo

cutaneous squamous cell carcinoma

Showing 26 - 50 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab, Ipilimumab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Amsterdam, Noord Holland, Netherlands
    NKI-AVL
Oct 24, 2022

Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Head Neck Cancer Trial in United States (Lenvatinib

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Oct 13, 2022

Cutaneous Squamous Cell Carcinoma, Skin Cancer, Squamous Cell Carcinoma Trial in United States (Cemiplimab, Radiotherapy)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +6 more
  • Aurora, Colorado
  • +11 more
Oct 12, 2022

Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Tampa (Excerise, Checkpoint Blockade,

Recruiting
  • Cutaneous Melanoma
  • +2 more
  • Excerise
  • Checkpoint Blockade, Immune
  • Tampa, Florida
    Moffitt Cancer Center
Sep 21, 2022

Melanoma Stage IV, Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Oslo (Fecal Microbiota

Recruiting
  • Melanoma Stage IV
  • +4 more
  • Fecal Microbiota Transplant (FMT)
  • Oslo, Norway
    Oslo University Hospital
Aug 29, 2022

Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Merkel Cell Carcinoma Trial (IFx-Hu2.0)

Available
  • Cutaneous Melanoma, Stage III
  • +3 more
  • IFx-Hu2.0
  • (no location specified)
Aug 5, 2022

Use of Cemiplimab in Adult Patients in UK

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • No intervention
  • Reading, Berkshire, United Kingdom
    Sanofi-Aventis UK
Aug 7, 2022

Decisional Conflicts, Health-related QoL and Satisfaction With

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +9 more
  • Regular care with additionally administration of questionnaires
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Jul 28, 2022

Cutaneous Squamous Cell Carcinoma Trial in Italy (Cemiplimab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Bagno A Ripoli, Firenze, Italy
  • +6 more
Jul 27, 2022

Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

Terminated
  • Melanoma
  • +8 more
  • GEN-011
  • +3 more
  • Gilbert, Arizona
  • +7 more
Jul 13, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Tampa, Durham (MEM-288 Intratumoral Injection)

Recruiting
  • Solid Tumor
  • +9 more
  • MEM-288 Intratumoral Injection
  • Tampa, Florida
  • +1 more
Jun 27, 2022

Cutaneous Squamous Cell Carcinoma Trial in Guangzhou (HLX07)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Jun 15, 2022

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck Trial in United States (Drug: SL-172154)

Terminated
  • Cutaneous Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Head and Neck
  • Drug: SL-172154
  • Los Angeles, California
  • +5 more
May 18, 2022

Cutaneous Squamous Cell Carcinoma Trial in Waratah, Melbourne, Nedlands (Imgatuzumab)

Suspended
  • Cutaneous Squamous Cell Carcinoma
  • Waratah, New South Wales, Australia
  • +2 more
May 17, 2022

Cutaneous Squamous Cell Carcinoma, Actinic Keratoses, Skin Cancer Trial in Boston, Saint Louis (Calcipotriol Only Product in

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +4 more
  • Calcipotriol Only Product in Cutaneous Dose Form
  • +2 more
  • Boston, Massachusetts
  • +1 more
Apr 5, 2022

Immunotherapy, Cutaneous Squamous Cell Carcinoma, Actinic Keratoses Trial in Boston, Saint Louis (Calcipotriol Only Product in

Not yet recruiting
  • Immunotherapy
  • +4 more
  • Calcipotriol Only Product in Cutaneous Dose Form
  • +2 more
  • Boston, Massachusetts
  • +1 more
Apr 5, 2022

Cutaneous Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in United States (RM-1995, Pembrolizumab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • RM-1995
  • Pembrolizumab
  • Duarte, California
  • +5 more
Apr 6, 2022

Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (Cemiplimab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Redwood City, California
  • +8 more
Mar 28, 2022

Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Non-Melanoma Skin Cancers Trial in United States (IFx-Hu2.0)

Recruiting
  • Merkel Cell Carcinoma
  • +2 more
  • IFx-Hu2.0
  • Los Angeles, California
  • +3 more
Apr 4, 2022

Cutaneous Squamous Cell Carcinoma Trial in Australia, Germany, United States (Cemiplimab)

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Palo Alto, California
  • +21 more
Apr 5, 2022

Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in Brandon (IFx-Hu2.0)

Completed
  • Cutaneous Squamous Cell Carcinoma
  • Basal Cell Carcinoma
  • IFx-Hu2.0
  • Brandon, Florida
    Moore Clinical Research
Apr 4, 2022

Cutaneous Squamous Cell Carcinoma, Sentinel Lymph Node Trial in Montreal (Sentinel Lymph Node Biopsy)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Sentinel Lymph Node
  • Sentinel Lymph Node Biopsy
  • Montreal, Quebec, Canada
    Jewish General Hospital
Apr 2, 2022

Head and Neck Squamous Cell Carcinoma, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma Trial in United States (NKTR-255,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • Scottsdale, Arizona
  • +11 more
Mar 31, 2022

Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Metastatic Cancer Trial in United States (CMP-001, cemiplimab-rwlc)

Recruiting
  • Merkel Cell Carcinoma
  • +4 more
  • Jacksonville, Florida
  • +6 more
Feb 24, 2022

Solid Tumor, Microsatellite Stable Colorectal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Canada, Korea,

Recruiting
  • Solid Tumor
  • +8 more
  • TBio-6517
  • Pembrolizumab
  • Phoenix, Arizona
  • +10 more
Feb 21, 2022